ELTX

Conviction 11HealthcareScan · Mon, Aug 10, 2026

ELTX$3.11-2.51%

ResistanceSupportVol 14

Vol MA14 329.41K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Elicio Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.elicio.com ↗

Price3.11

Change-2.51%

Gap+0.31%

Rel volume1.57×

Avg volume400.04K

Avg $ vol1.23M

SMA 203.05

SMA 505.56

SMA 2008.62

Price vs 50-44.10%

Price vs 200-63.93%

MA stackbearish

50/200 cross—

Supertrenddown · 3.88

RSI (14)40

MACD hist0.21

MACD cross—

Stoch %K / %D70 / 76

ADX (14)20

+DI / −DI20 / 28

RSI divergence—

MACD divergenceBearish

ATR %+12.60%

ADR %6.75%

52w high14.85

52w low2.76

From 52w high-79.06%

Above 52w low+12.68%

New 52w highNo

SqueezeOn · 8d

Bollinger width15.15%

%B0.62

Donchian pos60.94%

Donchian high3.36

Donchian low2.72

AVWAP (52w high)4.26

vs AVWAP high-27.01%

AVWAP (52w low)4.21

vs AVWAP low-26.09%

OBV trendDown

Chaikin MF (20)-0.18

Today vs 20d1.57×

Avg vol (14d)329.41K

Avg vol (20d)400.04K

Avg $ vol (20d)1.23M

Market cap59.36M

RS 3m (vs SPY)-73.83%

RS 6m (vs SPY)-72.20%

RS line new highNo

Trend template0/8

Technical rank5.8

1 week+8.74%

1 month-10.63%

3 months-68.62%

6 months-62.62%

1 year-65.71%

YTD-61.37%

P/E-1.50

P/B-41.31

P/S25.80

P/FCF-1.61

EPS-2.58

Div yield—

ROE—

ROA-174.41%

Debt/Eq-6.59

Current2.24

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-91.87%

EPS growth23.75%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value53.88M

Revenue0

Net income-11.82M

Gross profit—

Free cash flow-36.97M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out19.09M

Employees33

ListedFri, Jun 2, 2023

Free float11.01M

Float %63.0%

Short interest1.88M

Days to cover1.1d

Short volume57.0%

Squeeze score60 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction11 / 100

Pattern quality—

Tech rank5.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.01

Support2.69

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ELTX

All disclosures →

No recent disclosed trades by Congress in ELTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ELTX · 4 buys

Insider	Side	Shares	Value	Traded	Filed
Connelly Robert CEO, President and Director · Stock Option (Right to Buy) · 2026-07-16	Grant	186.94K	—	2026-07-16	2026-07-17
DeMuth Peter Chief Scientific Officer · Stock Option (Right to Buy) · 2026-07-16	Grant	52.83K	—	2026-07-16	2026-07-17
Haqq Christopher See Remarks · Stock Option (Right to Buy) · 2026-07-16	Grant	64.64K	—	2026-07-16	2026-07-17
Shah Preetam See Remarks · Stock Option (Right to Buy) · 2026-07-16	Grant	60.83K	—	2026-07-16	2026-07-17

SEC filings

EDGAR filings in ELTX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.